You Position: Home > Paper
结核分枝杆菌潜伏感染的化学预防干预
( views:355, downloads:1059 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Tuberculosis and Respiratory Diseases
- Issue:
- 1
- DOI:
- 10.3760/cma.j.issn.1001-0939.2016.01.005
- Key Word:
- No keyword available
Abstract： 2015年世界卫生组织在“MTB潜伏感染(latent TB infection,LTBI)诊治指南”[1]中,将LTBI定义为没有活动性结核病的临床表现,但机体持续存在对MTB抗原刺激的免疫应答的一种状态.虽然目前缺乏检测LTBI的直接手段和诊断“金标准”,但对于LTBI进行化学预防,是防治LTBI发展为活动性结核病的有效干预措施,结论较为肯定,尤其是在特定的人群中.
- [1]刘玉清,屠德华,安燕生,等.大学生结核病控制的研究：（二）结核感染者的预防性治疗[J].2005,(3).
- [2]刘二勇,成诗明,赖钰基,等.结核病预防性治疗研究进展[J].2014,(1).
- [3]肿瘤坏死因子拮抗剂应用中结核病预防与管理专家建议组.肿瘤坏死因子拮抗剂应用中结核病预防与管理专家共识[J].2013,(8).
- [4]胡京坤,吴喜娟,石淑娟.北京市西城区2004-2011年大学新生结核菌素监测与结核病预防性治疗价值评价[J].2013,(3).
- [5].Management of persons exposed to multidrug-resistant tuberculosis.[J].1992,41.
- [6]vanCrevel,R.,Hill,P.C.,Graham,S.M.,etc.Preventive therapy in children exposed to Mycobacterium tuberculosis: Problems and solutions[J].2012,17(10).
- [7]Mylonakis E,Ziakas PD.4 Months of Rifampin Compared with 9 Months of Isoniazid for the Management of Latent Tuberculosis Infection: A Meta-Analysis and Cost-Effectiveness Study That Focuses on Compliance and Liver Toxicity.[J].2009,49(12).
- [8]Miyasaka N,Eguchi K,Takeuchi T.Guidelines for the proper use of etanercept in Japan.[J].2006,16(2).
- [9]Martinson NA,Barnes GL,Moulton LH,etc.New regimens to prevent tuberculosis in adults with HIV infection.[J].2011,365(1).
- [10]Kurt, O. K.,Kurt, B.,Talay, F.,etc.Intermediate to long-term follow-up results of INH chemoprophylaxis prior to anti-TNF-alpha therapy in a high-risk area for tuberculosis[J].2013,125(19).
- [11]Parekh, M.J.,Schluger, N.W..Treatment of latent tuberculosis infection[J].2013,7(6).
- [12]Balcells, Maria Elvira,Thomas, Sara L.,Godfrey-Faussett, Peter,etc.Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis.[J].2006,12(5).
- [13]T, Moulding.How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?[J].2000,4(5).
- [14]Menzies D,Lobue P.Treatment of latent tuberculosis infection: An update.[J].2010,15(4).
- [15]M A, Steele,R F, Burk,R M, DesPrez.Toxic hepatitis with isoniazid and rifampin. A meta-analysis.[J].1991,99(2).
- [16]Zajdenverg R,Faulhaber JC,Chaisson RE,etc.Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.[J].2006,173(8).
- [17]Villarino ME,Hamilton CD,Menzies D,etc.Three months of rifapentine and isoniazid for latent tuberculosis infection.[J].2011,365(23).
- [18]Ena, Javier,Valls, Victoria.Short-Course Therapy with Rifampin plus Isoniazid, Compared with Standard Therapy with Isoniazid, for Latent Tuberculosis Infection: A Meta-analysis.[J].2005,40(5).
- [19].Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.[J].2011,60(48).